osilodrostat

Combination Osilodrostat and Cabergoline in Cushing's Disease

Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome

Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease

Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease

A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function

A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome